Literature DB >> 6066672

Lipid alterations in human brains in phenylketonuria.

B Gerstl, N Malamud, L F Eng, R B Hayman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6066672     DOI: 10.1212/wnl.17.1.51

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  11 in total

1.  Fatty acid composition of cerebrosides and cerebroside sulphatides in cerebral oedema.

Authors:  T Yanagihara; J N Cumings
Journal:  Acta Neuropathol       Date:  1968-12-18       Impact factor: 17.088

Review 2.  Phenylketonuria and its variations. A review of recent developments.

Authors:  M E Blaskovics; T L Nelson
Journal:  Calif Med       Date:  1971-07

3.  Lipid changes in the brain in phenylketonuria.

Authors:  J N Cumings; I K Grundt; T Yanagihara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-08       Impact factor: 10.154

4.  Galactolipid fatty acids in brain of pyridoxine-deficient young rats.

Authors:  M C Stephens; K Dakshinamurti
Journal:  Exp Brain Res       Date:  1976-07-28       Impact factor: 1.972

5.  Infantile spongy degeneration of the central nervous system associated with glycogen storage and markedly fatty liver.

Authors:  Y Takei; G B Solitare
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-02       Impact factor: 10.154

6.  Fatty acid composition of myelin lipids from developing rat forebrain and spinal cord: influence of experimental hyperphenylalaninaemia.

Authors:  G Huether; M Klapproth; V Neuhoff
Journal:  Neurochem Res       Date:  1986-09       Impact factor: 3.996

7.  The effect of phenylpyruvate on pyruvate metabolism in rat brain.

Authors:  M S Patel
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

8.  Effects of alpha-methylphenylalanine plus phenylalanine treatment during development on myelin in rat brain.

Authors:  R C Johnson; S N Shah
Journal:  Neurochem Res       Date:  1980-07       Impact factor: 3.996

9.  "PKU bodies": characteristic inclusions in the brain in phenylketonuria.

Authors:  F T Oteruelo
Journal:  Acta Neuropathol       Date:  1976-12-21       Impact factor: 17.088

10.  Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia.

Authors:  M Castillo; M F Zafra; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1988-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.